MPLT · ISSUER CIK 1770069
MapLight Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 7 MapLight Therapeutics, Inc. insiders reported $50.1M of open-market purchases and $1.5M of sales on SEC Form 4. The largest buyer was Catalyst4, Inc. (10% Owner), with $50.1M.
↗7 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 8 sales were reported under a 10b5-1 plan.
$50.1MInsider buying
$1.5MInsider selling
+$48.5MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | Chief Discovery Officer | S · Sell | $7.84 | −12,248 | 168,678 | -7% | −$96K | ||
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | CAO and Interim CFO | S · Sell | $8.08 | −10,167 | 142,315 | -7% | −$82K | ||
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | Chief Scientific Officer | S · Sell | $8.08 | −11,513 | 198,597 | -5% | −$93K | ||
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | General Counsel | S · Sell | $8.08 | −9,020 | 128,024 | -7% | −$73K | ||
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | Chief Medical Officer | S · Sell | $8.08 | −15,355 | 296,906 | -5% | −$124K | ||
| Oct 16, 202617:00 | Oct 15, 2026 | MPLT | Chief Executive Officer, Director | S · Sell | $8.08 | −73,691 | 1,195,909 | -6% | −$595K | ||
| Sep 18, 202616:15 | Sep 16, 2026 | MPLT | General Counsel | S · Sell10b5-1 | $11.67 | −16,509 | 137,044 | -11% | −$193K | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | Chief Discovery Officer | A · Grant | — | +6,020 | 180,926 | +3% | — | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | CAO and Interim CFO | A · Grant | — | +8,242 | 152,482 | +6% | — | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | Chief Scientific Officer | A · Grant | — | +7,730 | 210,110 | +4% | — | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | General Counsel | A · Grant | — | +7,730 | 153,553 | +5% | — | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | Chief Medical Officer | A · Grant | — | +13,360 | 312,261 | +4% | — | ||
| Aug 19, 202618:35 | Aug 17, 2026 | MPLT | Chief Executive Officer, Director | A · Grant | — | +23,145 | 1,269,600 | +2% | — | ||
| Aug 18, 202618:55 | Aug 14, 2026 | MPLT | 10% Owner | P · Buy | $11.38 | +4,400,000 | 25,306,689 | +21% | +$50.1M | -71.4% | -32.2% |
| Aug 4, 202620:39 | Aug 3, 2026 | MPLT | Chief Scientific Officer | S · Sell10b5-1 | $12.54 | −22,082 | 202,380 | -10% | −$277K |